David Zhang

David Zhang, Ph.D., is our senior vice president and chief information officer. Before joining Alumis, he was vice president of biometrics, data science and digital health at Bristol Myers Squibb following the company’s acquisition of MyoKardia. At MyoKardia, David built the advanced analytics capabilities from ground up to enable the successful completion of critical data readouts and New Drug Application submission. David has over two decades of industry experience spanning from biopharma to diagnostics product development. Prior to MyoKardia, David spent 15 years at Roche/Genentech with increasing responsibilities leading and building biostatistics and strategic innovation functions. David began his pharmaceutical industry career at Eli Lilly and Abbott Laboratories. He received his Ph.D. in biostatistics with a minor in genetics from UCLA School of Public Health and completed post-doctoral research at Columbia University.